# Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

> **NCT06360380** · NA · RECRUITING · sponsor: **AquaPass Medical Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Heart Failure
- CKD Stage 3

## Interventions

- **DEVICE:** AquaPass System

## Key facts

- **NCT ID:** NCT06360380
- **Lead sponsor:** AquaPass Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-05
- **Primary completion:** 2025-01-03
- **Final completion:** 2025-01-29
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360380, "Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06360380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*